SPADI — Shoulder Pain and Disability Index
Self-administered shoulder outcome measure (Roach 1991). 5 pain + 8 disability items, each scored 0–10 (NRS). Raw total /130; normalised to 0–100% by dividing by 130 and ×100. Higher = worse. Minimum clinically important difference ≈8 points.
Score interpretation
→ Conservative care: NSAIDs, physiotherapy (eccentric rotator-cuff strengthening), activity modification.
→ Structured physiotherapy programme; consider US-guided subacromial corticosteroid injection if impingement; imaging (US/MRI) if symptoms >6 weeks.
→ Refer to upper-limb orthopaedic clinic. MRI to characterise rotator cuff / labrum / OA. Consider arthroscopic decompression, cuff repair, or arthroplasty as indicated.
Interpretation bands for the SPADI. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Methoxyflurane · Inhaled Analgesic — Acute Pain
- Fentanyl Transdermal Patch (Elderly Chronic Pain) · Opioid Analgesic — Transdermal Patch
- Morphine Slow-Release (Elderly Chronic Pain) · Opioid Analgesic — Modified-Release Oral
- Amitriptyline (Neuropathic Pain / Migraine) · Tricyclic Antidepressant / Neuropathic Pain Agent
- Gabapentin · Alpha-2-Delta Ligand — Neuropathic Pain / Epilepsy Adjunct
- Diclofenac (Dysmenorrhoea / Post-gynaecological Procedure) · NSAID — Gynaecological Pain
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.